Open

Coming up

Don't miss

Replay


LATEST SHOWS

AFRICA NEWS

Search of Air Algerie crash site continues

Read more

MEDIAWATCH

Sarkozy, Hollande and the scooter wars

Read more

MEDIAWATCH

Confusion online over Air Algérie flight

Read more

THE WORLD THIS WEEK

The World This Week - July 25th, 2014 (part 2)

Read more

THE WORLD THIS WEEK

The World This Week - July 25th, 2014

Read more

REPORTERS

Halal tourism on the rise

Read more

ENCORE!

Tunisia's Carthage International Festival turns 50

Read more

FRANCE IN FOCUS

WWI Centenary: the battle for Verdun

Read more

THE BUSINESS INTERVIEW

When big companies want to do good

Read more

  • In pictures: Debris and devastation at Air Algérie Flight AH5017 crash scene

    Read more

  • Kerry heads to Paris for new round of Gaza peace talks

    Read more

  • Video: No investigation apparent at site of downed Malaysian plane

    Read more

  • Washington Post correspondent and his wife arrested in Iran

    Read more

  • Paris bans new Gaza protest scheduled for Saturday

    Read more

  • Tour de France fans bring the ambience to the Pyrenees

    Read more

  • French families grieve for Algerian plane crash victims

    Read more

  • Protest against Gaza offensive turns deadly in West Bank

    Read more

  • Halal tourism on the rise

    Read more

  • LA Times wipes France off the map in air crash infographic

    Read more

  • Lithuania’s Navardauskas wins 19th stage of Tour de France

    Read more

  • French lawyer files complaint against Israel at ICC

    Read more

  • Ukraine names acting PM after Yatseniuk's shock resignation

    Read more

  • BNP to pay $80 million for defrauding Dept of Agriculture

    Read more

  • Deadly strike on UN shelter in Gaza Strip

    Read more

  • Pope meets Christian woman sentenced to death in Sudan

    Read more

France

France gives go-ahead to cannabis-based drug

© GW Pharmaceuticals

Text by FRANCE 24

Latest update : 2014-01-09

France’s health ministry announced Thursday it had approved the use of Sativex, a cannabinoid mouth spray, to treat patients suffering from multiple sclerosis (MS). The drug is the first marijuana-based medicine to be made available in the country.

While the decision to approve Sativex may seem revolutionary for France, the prescription of the drug will be extremely limited. The spray will only be recommended for MS patients with “severe muscle spasms (spasticity), resistant to other treatments,” according to the health ministry, which also specified that only neurologists and physical therapists will have the right to prescribe it at first.

Once on the market, Sativex can prescribed for up to six months, the national health monitoring agency (which approved the drug and set its conditions of use) told French daily Le Monde in a statement. The medication will be available at pharmacies, where it will be stocked in a safe with other opiate-based drugs.

French Health Minister Marisol Touraine first raised the issue of approving cannabis-based medications in June, when she signed an order authorising the national health agency to look at requests to commercialise such products. Although many countries – including Holland, Canada, Germany, Britain and even some US states – already allow the use of medical marijuana, France has been hesitant to embrace the drug’s therapeutic properties until now.

Sativex, which is made by the British company GW Pharmaceuticals and has already been approved in more than 20 countries, still has a few hoops to jump through before hitting the French market. It must go through the country’s highest health body before a price and reimbursement rate can be decided. The drug is expected to be made available in 2015.

(FRANCE 24 with AFP)

Date created : 2014-01-09

  • USA

    Marijuana shops open in Colorado

    Read more

  • URUGUAY

    Uruguay votes to legalise marijuana production

    Read more

  • USA

    Californians reject proposal to legalise marijuana

    Read more

COMMENT(S)